RPRX insider buying and SEC filings, explained
Royalty Pharma plc · CIK 1802768
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- X0
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$92.8M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 5, 2026 | Planned (10b5-1) | Marshall Urist (EVP, Research & Investments) sold 4,126 shares at $57.10 ($236K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Oct 5, 2026, 5:12 PM ET |
| Sep 28, 2026 | Planned (10b5-1) | Marshall Urist (EVP, Research & Investments) sold 4,126 shares at $57.88 ($239K), marked as a 10b5-1 plan trade. Holdings down 50% to 4,126 shares. | SEC filing Filed Sep 30, 2026 |
| Sep 22, 2026 | Planned (10b5-1) | Christopher Hite (Chair) sold 100,000 shares indirectly (by entity) at about $58.53 ($5.9M), marked as a 10b5-1 plan trade. Holdings by entity down 27% to 270,401 shares. | SEC filing Filed Sep 24, 2026 |
| Aug 18, 2026 | Planned (10b5-1) | Christopher Hite (Chair) sold 100,000 shares indirectly (by entity) at about $59.97 ($6.0M), marked as a 10b5-1 plan trade. Holdings by entity down 21% to 370,401 shares. | SEC filing Filed Aug 19, 2026 |
| Aug 13, 2026 | Planned (10b5-1) | Terrance P. Coyne (CFO) sold 11,002 shares indirectly (by entity) at about $58.68 ($646K), marked as a 10b5-1 plan trade. Holdings by entity down 100% to 0 shares. | SEC filing Filed Aug 17, 2026 |
| Jul 1, 2026 | Planned (10b5-1) | Marshall Urist (EVP, Research & Investments) sold 9,099 shares at about $55.88 ($508K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jul 2, 2026 |
| Jun 30, 2026 | Planned (10b5-1) | Christopher Hite (Chair) sold 130,000 shares directly and indirectly (by entity) at about $56.50 ($7.3M), marked as a 10b5-1 plan trade. Direct holdings down 43% to 40,000 shares. | SEC filing Filed Jul 2, 2026 |
| Jun 24, 2026 | Planned (10b5-1) | Marshall Urist (EVP, Research & Investments) sold 9,098 shares at about $55.18 ($502K), marked as a 10b5-1 plan trade. Holdings down 50% to 9,099 shares. | SEC filing Filed Jun 25, 2026 |
| Jun 23, 2026 | Planned (10b5-1) | Christopher Hite (Chair) sold 150,000 shares indirectly (by entity) at about $54.39 ($8.2M), marked as a 10b5-1 plan trade. Holdings by entity down 21% to 559,399 shares. | SEC filing Filed Jun 25, 2026 |
| May 26, 2026 | Planned (10b5-1) | Terrance P. Coyne (CFO) sold 64,399 shares indirectly (by entity) at about $53.98 ($3.5M), marked as a 10b5-1 plan trade. Holdings by entity down 100% to 0 shares. | SEC filing Filed May 28, 2026 |
| May 20, 2026 | Planned (10b5-1) | Marshall Urist (EVP, Research & Investments) sold 13,684 shares at about $52.75 ($722K), marked as a 10b5-1 plan trade. Holdings down 43% to 18,197 shares. | SEC filing Filed May 21, 2026 |
| May 14, 2026 | Planned (10b5-1) | Marshall Urist (EVP, Research & Investments) sold 13,684 shares at about $53.06 ($726K), marked as a 10b5-1 plan trade. Holdings down 30% to 31,881 shares. | SEC filing Filed May 15, 2026 |
| May 14, 2026 | Planned (10b5-1) | Gregory Norden (Director) sold 3,045 shares at $53.00 ($161K), marked as a 10b5-1 plan trade. Holdings down 2% to 191,803 shares. | SEC filing Filed May 15, 2026 |
| Apr 28, 2026 | Planned (10b5-1) | Terrance P. Coyne (CFO) sold 34,791 shares indirectly (by entity) at about $49.78 ($1.7M), marked as a 10b5-1 plan trade. Holdings by entity down 100% to 0 shares. | SEC filing Filed Apr 30, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Terrance P. Coyne (CFO) sold 34,791 shares indirectly (by entity) at about $48.33 ($1.7M), marked as a 10b5-1 plan trade. Holdings by entity down 50% to 32,916 shares. | SEC filing Filed Apr 2, 2026 |
| Mar 23, 2026 | Planned (10b5-1) | Terrance P. Coyne (CFO) sold 34,791 shares indirectly (by entity) at about $45.53 ($1.6M), marked as a 10b5-1 plan trade. Holdings by entity down 33% to 65,832 shares. | SEC filing Filed Mar 25, 2026 |
| Mar 2, 2026 | Planned (10b5-1) | Terrance P. Coyne (CFO) sold 34,791 shares indirectly (by entity) at about $46.78 ($1.6M), marked as a 10b5-1 plan trade. Holdings by entity down 25% to 98,748 shares. | SEC filing Filed Mar 4, 2026 |
| Feb 23, 2026 | Planned (10b5-1) | Terrance P. Coyne (CFO) sold 34,791 shares indirectly (by entity) at about $45.32 ($1.6M), marked as a 10b5-1 plan trade. Holdings by entity down 20% to 131,664 shares. | SEC filing Filed Feb 25, 2026 |
| Feb 2–4, 2026 | Planned (10b5-1) | Terrance P. Coyne (CFO) sold 243,541 shares indirectly (by entity) between Feb 2 and Feb 4 at about $42.54 ($10.4M), marked as a 10b5-1 plan trade. Holdings by entity down 58% to 164,580 shares. | SEC filing Filed Feb 4, 2026 |
| Jan 30, 2026 | Planned (10b5-1) | Marshall Urist (EVP, Research & Investments) sold 20,000 shares indirectly (by entity) at about $41.09 ($822K), marked as a 10b5-1 plan trade. Holdings by entity down 100% to 0 shares. | SEC filing Filed Feb 2, 2026 |
| Jan 23, 2026 | Planned (10b5-1) | Marshall Urist (EVP, Research & Investments) sold 20,000 shares indirectly (by entity) at about $40.26 ($805K), marked as a 10b5-1 plan trade. Holdings by entity down 50% to 20,000 shares. | SEC filing Filed Jan 26, 2026 |
| Jan 20, 2026 | Planned (10b5-1) | Terrance P. Coyne (CFO) sold 69,582 shares indirectly (by entity) at about $39.35 ($2.7M), marked as a 10b5-1 plan trade. Holdings by entity down 14% to 394,996 shares. | SEC filing Filed Jan 23, 2026 |
| Jan 16, 2026 | Planned (10b5-1) | Marshall Urist (EVP, Research & Investments) sold 20,000 shares indirectly (by entity) at about $39.52 ($790K), marked as a 10b5-1 plan trade. Holdings by entity down 33% to 40,000 shares. | SEC filing Filed Jan 20, 2026 |
| Jan 9, 2026 | Planned (10b5-1) | Marshall Urist (EVP, Research & Investments) sold 20,000 shares indirectly (by entity) at about $40.78 ($816K), marked as a 10b5-1 plan trade. Holdings by entity down 25% to 60,000 shares. | SEC filing Filed Jan 13, 2026 |
| Jan 2, 2026 | Planned (10b5-1) | Marshall Urist (EVP, Research & Investments) sold 20,000 shares indirectly (by entity) at about $38.48 ($770K), marked as a 10b5-1 plan trade. Holdings by entity down 20% to 80,000 shares. | SEC filing Filed Jan 6, 2026 |
| Jan 2, 2026 | Planned (10b5-1) | Terrance P. Coyne (CFO) sold 69,582 shares indirectly (by entity) at about $38.42 ($2.7M), marked as a 10b5-1 plan trade. Holdings by entity down 12% to 460,828 shares. | SEC filing Filed Jan 6, 2026 |
| Dec 26, 2025 | Planned (10b5-1) | Marshall Urist (EVP, Research & Investments) sold 20,000 shares indirectly (by entity) at about $39.32 ($786K), marked as a 10b5-1 plan trade. Holdings by entity down 17% to 100,000 shares. | SEC filing Filed Dec 29, 2025 |
| Dec 19, 2025 | Planned (10b5-1) | Marshall Urist (EVP, Research & Investments) sold 20,000 shares indirectly (by entity) at about $38.38 ($768K), marked as a 10b5-1 plan trade. Holdings by entity down 14% to 120,000 shares. | SEC filing Filed Dec 22, 2025 |
| Dec 17–18, 2025 | Planned (10b5-1) | George W. Lloyd (EVP, Investments & CLO) sold 110,000 shares indirectly (by entity) between Dec 17, 2025 and Dec 18, 2025 at about $38.55 ($4.2M), marked as a 10b5-1 plan trade. Holdings by entity down 100% to 0 shares. | SEC filing Filed Dec 19, 2025 |
| Dec 16, 2025 | Planned (10b5-1) | Marshall Urist (EVP, Research & Investments) sold 20,000 shares indirectly (by entity) at about $38.32 ($766K), marked as a 10b5-1 plan trade. Holdings by entity down 13% to 140,000 shares. | SEC filing Filed Dec 17, 2025 |
| Dec 15, 2025 | Planned (10b5-1) | Terrance P. Coyne (CFO) sold 69,582 shares indirectly (by entity) at about $38.36 ($2.7M), marked as a 10b5-1 plan trade. Holdings by entity down 11% to 526,660 shares. | SEC filing Filed Dec 17, 2025 |
| Dec 5, 2025 | Planned (10b5-1) | Marshall Urist (EVP, Research & Investments) sold 41,576 shares directly and indirectly (by entity) at about $39.15 ($1.6M), marked as a 10b5-1 plan trade. Direct holdings down 71% to 7,398 shares. | SEC filing Filed Dec 9, 2025 |
| Dec 3, 2025 | Planned (10b5-1) | George W. Lloyd (EVP, Investments & CLO) sold 110,000 shares indirectly (by entity) at about $39.77 ($4.4M), marked as a 10b5-1 plan trade. Holdings by entity down 50% to 110,000 shares. | SEC filing Filed Dec 5, 2025 |
| Dec 1, 2025 | Planned (10b5-1) | Marshall Urist (EVP, Research & Investments) sold 41,575 shares directly and indirectly (by entity) at about $39.92 ($1.7M), marked as a 10b5-1 plan trade. Direct holdings down 42% to 25,640 shares. | SEC filing Filed Dec 3, 2025 |
| Dec 1, 2025 | Planned (10b5-1) | Terrance P. Coyne (CFO) sold 69,582 shares indirectly (by entity) at about $39.87 ($2.8M), marked as a 10b5-1 plan trade. Holdings by entity down 10% to 592,492 shares. | SEC filing Filed Dec 3, 2025 |
| Nov 24, 2025 | Planned (10b5-1) | Terrance P. Coyne (CFO) sold 69,582 shares indirectly (by entity) at about $38.55 ($2.7M), marked as a 10b5-1 plan trade. Holdings by entity down 9% to 658,324 shares. | SEC filing Filed Nov 26, 2025 |
| Nov 19, 2025 | Planned (10b5-1) | George W. Lloyd (EVP, Investments & CLO) sold 135,426 shares directly and indirectly (by entity) at about $38.34 ($5.2M), marked as a 10b5-1 plan trade. Direct holdings down 100% to 0 shares. | SEC filing Filed Nov 21, 2025 |
| Nov 17, 2025 | Planned (10b5-1) | Terrance P. Coyne (CFO) sold 69,594 shares indirectly (by entity) at about $39.30 ($2.7M), marked as a 10b5-1 plan trade. Holdings by entity down 8% to 724,156 shares. | SEC filing Filed Nov 19, 2025 |
30 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow RPRX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.